243 related articles for article (PubMed ID: 34040582)
1. The Role of Inositol in Thyroid Physiology and in Subclinical Hypothyroidism Management.
Benvenga S; Nordio M; Laganà AS; Unfer V
Front Endocrinol (Lausanne); 2021; 12():662582. PubMed ID: 34040582
[TBL] [Abstract][Full Text] [Related]
2. Myoinositol in Autoimmune Thyroiditis.
Paparo SR; Ferrari SM; Patrizio A; Elia G; Ragusa F; Botrini C; Balestri E; Guarneri F; Benvenga S; Antonelli A; Fallahi P
Front Endocrinol (Lausanne); 2022; 13():930756. PubMed ID: 35837308
[TBL] [Abstract][Full Text] [Related]
3. Myo-inositol in autoimmune thyroiditis, and hypothyroidism.
Fallahi P; Ferrari SM; Elia G; Ragusa F; Paparo SR; Caruso C; Guglielmi G; Antonelli A
Rev Endocr Metab Disord; 2018 Dec; 19(4):349-354. PubMed ID: 30506520
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of thyroid nodule characteristics in subclinical hypothyroid patients under a myo-inositol plus selenium treatment.
Nordio M; Basciani S
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):2153-2159. PubMed ID: 29687875
[TBL] [Abstract][Full Text] [Related]
5. Role of selenium and myo-inositol supplementation on autoimmune thyroiditis progression.
Pace C; Tumino D; Russo M; Le Moli R; Naselli A; Borzì G; Malandrino P; Frasca F
Endocr J; 2020 Nov; 67(11):1093-1098. PubMed ID: 32669509
[TBL] [Abstract][Full Text] [Related]
6. Myo-inositol plus selenium supplementation restores euthyroid state in Hashimoto's patients with subclinical hypothyroidism.
Nordio M; Basciani S
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(2 Suppl):51-59. PubMed ID: 28724185
[TBL] [Abstract][Full Text] [Related]
7. Myo-inositol and selenium reduce the risk of developing overt hypothyroidism in patients with autoimmune thyroiditis.
Ferrari SM; Fallahi P; Di Bari F; Vita R; Benvenga S; Antonelli A
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(2 Suppl):36-42. PubMed ID: 28724175
[TBL] [Abstract][Full Text] [Related]
8. Supplementation with myo-inositol and Selenium improves the clinical conditions and biochemical features of women with or at risk for subclinical hypothyroidism.
Payer J; Jackuliak P; Kužma M; Džupon M; Vaňuga P
Front Endocrinol (Lausanne); 2022; 13():1067029. PubMed ID: 36465640
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment with Myo-inositol and selenium ensures euthyroidism in subclinical hypothyroidism patients with autoimmune thyroiditis.
Nordio M; Pajalich R
J Thyroid Res; 2013; 2013():424163. PubMed ID: 24224112
[TBL] [Abstract][Full Text] [Related]
10. Treatment with Myo-Inositol and Selenium Ensures Euthyroidism in Patients with Autoimmune Thyroiditis.
Nordio M; Basciani S
Int J Endocrinol; 2017; 2017():2549491. PubMed ID: 28293260
[TBL] [Abstract][Full Text] [Related]
11. The impact of vitamin D on thyroid autoimmunity and hypothalamic-pituitary-thyroid axis activity in myo-inositol-treated and myo-inositol-naïve women with autoimmune thyroiditis: A pilot study.
Krysiak R; Kowalcze K; Okopień B
J Clin Pharm Ther; 2022 Nov; 47(11):1759-1767. PubMed ID: 35775148
[TBL] [Abstract][Full Text] [Related]
12. Differences in levothyroxine action on thyroid autoimmunity and hypothalamic-pituitary-thyroid axis activity between metformin- and myo-inositol-treated women with autoimmune subclinical hypothyroidism.
Krysiak R; Kowalcze K; Okopień B
J Clin Pharm Ther; 2022 Oct; 47(10):1704-1710. PubMed ID: 35768336
[TBL] [Abstract][Full Text] [Related]
13. Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Croze ML; Soulage CO
Biochimie; 2013 Oct; 95(10):1811-27. PubMed ID: 23764390
[TBL] [Abstract][Full Text] [Related]
14. Relative contribution of phosphoinositides and phosphatidylcholine hydrolysis to the actions of carbamylcholine, thyrotropin (TSH), and phorbol esters on dog thyroid slices: regulation of cytidine monophosphate-phosphatidic acid accumulation and phospholipase-D activity. I. Actions of carbamylcholine, calcium ionophores, and TSH.
Lejeune C; Mockel J; Dumont JE
Endocrinology; 1994 Dec; 135(6):2488-96. PubMed ID: 7988436
[TBL] [Abstract][Full Text] [Related]
15. Regulation of myo-inositol transport during the growth and differentiation of thyrocytes: a link with thyroid-stimulating hormone-induced phospholipase A2 activity.
Grafton G; Baxter MA; Sheppard MC; Eggo MC
Biochem J; 1995 Jul; 309 ( Pt 2)(Pt 2):667-75. PubMed ID: 7626034
[TBL] [Abstract][Full Text] [Related]
16. Selenium nanoparticles prevents lead acetate-induced hypothyroidism and oxidative damage of thyroid tissues in male rats through modulation of selenoenzymes and suppression of miR-224.
Atteia HH; Arafa MH; Prabahar K
Biomed Pharmacother; 2018 Mar; 99():486-491. PubMed ID: 29665650
[TBL] [Abstract][Full Text] [Related]
17. Phosphoinositides metabolism in primary culture of dog thyroid cells: effects of thyrotropin and carbachol.
Taguchi M; Field JB
Metabolism; 1990 Apr; 39(4):418-24. PubMed ID: 2157940
[TBL] [Abstract][Full Text] [Related]
18. Investigating the effect of combined use of selenium and Myo-inositol supplements on thyroid function and autoimmune characteristics in thyroid disorders: a systematic review and meta-analysis.
Yavari M; Akbari M; Ramezani Ahmadi A; Siavash Dastjerdi M; Hashemi MS
Expert Rev Endocrinol Metab; 2024 May; 19(3):269-277. PubMed ID: 38147023
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Follow-Up and Outcomes of Autoimmune Thyroiditis in Childhood.
Admoni O; Rath S; Almagor T; Elias-Assad G; Tenenbaum-Rakover Y
Front Endocrinol (Lausanne); 2020; 11():309. PubMed ID: 32582023
[No Abstract] [Full Text] [Related]
20. Incidence of antibodies blocking thyrotropin effect in vitro in patients with euthyroid or hypothyroid autoimmune thyroiditis.
Chiovato L; Vitti P; Santini F; Lopez G; Mammoli C; Bassi P; Giusti L; Tonacchera M; Fenzi G; Pinchera A
J Clin Endocrinol Metab; 1990 Jul; 71(1):40-5. PubMed ID: 2164529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
